Clinical trial
Smoking Relapse Prevention in Schizophrenia
NCT00320697 · North Suffolk Mental Health Association, Other · Completed
Key facts
| NCT number | NCT00320697 |
|---|---|
| Title | Smoking Relapse Prevention in Schizophrenia |
| Official title | A Trial of the Effects of Bupropion, Nicotine Replacement Therapy and CBT on Smoking Cessation and Smoking Relapse in Patients With Schizophrenia |
| Lead sponsor | North Suffolk Mental Health Association, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia, Schizoaffective Disorder, Smokers |
| Intervention type | Drug |
| Interventions | bupropion + nicotine patch + nicotine gum or lozenges, Placebo pill + placebo patch |
| Enrollment | 25 |
| Start date | Apr 1, 2006 |
| Primary completion | Oct 1, 2008 |
| Completion | Aug 1, 2009 |
| First posted | May 3, 2006 |
| Last update posted | Sep 27, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: